Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo
© Kato et al.; licensee BioMed Central Ltd. 2013
Received: 29 July 2012
Accepted: 10 December 2012
Published: 3 January 2013
The physiological function of p38α, which is an isoform of p38 MAPK, has been investigated previously in several studies using pharmacological inhibitors. However, the results regarding whether p38α promotes or inhibits nerve regeneration in vivo have been controversial.
We generated novel p38α mutant mice (sem mice) with a point mutation in the region encoding the p38α substrate-docking-site, which serves as a limited loss-of-function model of p38α. In the present study, we utilized sem mice and wild-type littermates (wt mice) to investigate the physiological role of p38α in nerve regeneration following crush injuries.
At four weeks after crush injury, the average axon diameter and the average axon area in sem mice were significantly smaller than those in wt mice. The average myelin sheath thickness in sem mice was reduced compared to wt mice, but no significant difference was observed in the G-ratio between the two groups. The sciatic functional index value demonstrated that functional nerve recovery in sem mice following crush injury was delayed, which is consistent with the histological findings. To investigate the underlying mechanisms of these findings, we examined inflammatory responses of the sciatic nerve by immunohistochemistry and western blotting. At an early phase following crush injury, sem mice showed remarkably lower expression of inflammatory cytokines, such as TNF-α and IL-1β, than wt mice. The expression of Caspase-3 and Tenascin-C were also lower in sem mice. Conversely, at a late phase of the response, sem mice showed considerably higher expression of TNF-α and of IL-1β with lower expression of S-100 than wt mice.
This is the first study of the physiological role of p38 MAPK in nerve regeneration that does not rely on the use of pharmacological inhibitors. Our results indicate that p38α insufficiency may cause an inflammatory disorder, resulting in a delay of histological and functional nerve recovery following crush injury. We conclude that p38 MAPK has an important physiological role in nerve regeneration and may be important for controlling both initiation of inflammation and recovery from nerve injury.
KeywordsP38 MAPK Nerve regeneration Crush injury Inflammatory cytokines TNF-α IL-1β Mutant mice In vivo
It is well known that the peripheral nervous system is remarkable in its ability to regenerate after injury. In the transected or crushed peripheral nerve, the distal segment undergoes Wallerian degeneration, which is essential for the subsequent processes of nerve regeneration . Therefore, understanding the molecular mechanisms between nerve degeneration and regeneration holds the key to further advances in the clinical management of such injuries. In the event of nerve regeneration, cytokines have been considered to be critical components, since these are important mediators of communication between various types of cells. Furthermore, it has been reported that expression of cytokines, including pro- and anti-inflammatory cytokines, are controlled in a highly ordered fashion during Wallerian degeneration and subsequent regeneration in the peripheral nerve system [2, 3]. Of these pro-inflammatory cytokines, TNF-α is upregulated early and transiently at the site of nerve injury and is considered to play a crucial role in the process of Wallerian degeneration as an initiator of local inflammatory responses [2, 4]. However, the complex signaling pathways controlling these events remain unknown. Further understanding of the cell and molecular program controlling the expression of inflammatory cytokines following nerve injuries is important in order to devise ways to promote nerve regeneration.
Mitogen-activated protein kinase (MAPK) cascades are highly conserved signal transduction pathways coupling different extracellular signals to a variety of intracellular responses . The signaling pathway is similar for all the members of the MAPK family and is typically composed of a highly conserved MAPK module comprising three kinases, namely MAPK kinase kinase (MKKK), MAPK kinase (MKK) and MAPK. The p38 MAPK is a member of this MAPK family of serine-threonine kinases, which is specifically activated by phosphorylation under conditions of hypoxia, stress, and exposure to inflammatory cytokines . Activated p38 MAPK subsequently phosphorylates its substrates, including protein kinases such as MAPKAP kinase-2 and several transcription factors including MEF2, CHOP, and ATF-2, leading to the induction of cell proliferation and/or apoptosis . In this pathway, dephosphorylation of either Thr180 or Tyr182 is sufficient to inactivate p38 MAPK, and this can be mediated by tyrosine-specific MAPK phosphatases. The MAPK cascade can also induce phosphatase gene transcription, providing a negative feedback for MAPK activation.
It has been reported that p38 MAPK has four isoforms, p38α, p38β, p38γ, and p38δ, which share 60% to 70% amino acid sequence identity. Although these isoforms have overlapping substrate specificity, some substrates appear to be preferentially phosphorylated by one or more isoforms . Of these isoforms, p38α is expressed ubiquitously and has been proposed to regulate many cellular processes. In the nervous system, it has been reported that p38α plays critical roles in the differentiation and/or survival of neurons, regulating neural plasticity and inflammatory responses. Considering that inflammatory responses induced by nerve injury are indispensable for subsequent nerve regeneration, further investigation of the p38α signaling pathway may be a key to understanding the mechanisms regulating nerve regeneration.
There are a large number of reports regarding p38α function in cultured cells. However, very little is known about the physiological role of this MAPK in vivo, since p38α is essential for mammalian embryonic development and loss of p38α causes embryonic death [9, 10]. In vivo studies to investigate p38 MAPK function have usually been undertaken using pharmacological inhibitors, such as SB 203580, which targets both p38α and p38β . However, the physiological function of p38 MAPK in vivo remains controversial. Temporin et al. reported that SB 203580 reduced axonal length in a neurite outgrowth assay. In that study, the activation of RhoA appeared to be responsible for this effect, since the addition of SB 203580 increased RhoA activity to 2.1-fold compared with control group . On the other hand, Myers et al. found that SD-169, a novel oral inhibitor of p38 MAPK, increased the rate of nerve fiber regeneration following peripheral nerve crush injury . The reasons for these conflicting results are not entirely clear, however, we surmise that the specificity of these chemical inhibitors, critically depending on their concentration, might be a contributing factor. Godl et al. studied the selectivity of SB 203580, widely used as a p38 MAPK inhibitor, using a proteomics approach and reported that RICK (Rip-like interacting caspase-like apoptosis-regulatory protein kinase/RIP2/CARDIAK) was even more potently inhibited by SB 203580 than p38α. Since RIP2/RICK/CARDIAK is a member of the receptor interacting protein kinase (RIP) family and promotes NF-κB activation as well as activation of the MAPKs JNK, ERK1/2 and p38 MAPK, these authors commented that incorrect conclusions might have been drawn from numerous experiments, in which SB 203580 was used as a ‘specific’ p38 inhibitor . Thus, to understand the precise physiological functions of p38α in vivo, more specific methods than pharmacological inhibition are required.
It has been reported that docking interactions of MAPKs via docking domains are important in regulating both the activation and inactivation of these kinases, and mutation of this docking domain in p38α/p38β disrupted the p38 docking interaction, resulting in dysfunction of p38α and p38β . In this domain, two aspartate acids are essential for docking and the so-called sevenmaker mutant, in which one of these two aspartate acids is changed, showed markedly decreased kinase activity on MAPK phosphatase-1 in vitro[16, 17].
Recently, we generated novel p38α mutant mice with a point mutation in the p38α substrate-docking-site. Using the Cre/lox-conditional mutation system, we converted aspartate acid at position 316 in exon 11 of p38α to asparagine. As a result, these mutant mice, termed sem (sevenmaker type Mapk14) mice, possess a knock-in mutation in p38 MAPK (D316N) . In the present study, we utilized these sem mice and wild-type littermates (wt mice) to investigate the physiological role of p38α during nerve regeneration following crush injury.
Materials and methods
Sem C57BL/6N mice were bred with wt C57BL/6N mice. Approximately half of the resulting offspring carried the mutant p38α gene, as confirmed by polymerase chain reaction (PCR) genotyping with primers specific for the mutant p38α gene, 5′-TAG ATA CAG AGC CAT CAG ACC ACC A-3′ (sense primer) and 5′-TGA ATG GTG TAG CAT AGG CTG GA-3′ (antisense primer), applied to total cellular DNA isolated from tail snip tissue. Adult, male, sem mice with heterozygous mutant p38α gene (p38+/−) (12 to 16 weeks old, weighing 13 to 22 g) and wt littermates (p38+/+) (12 to 16 weeks old, weighing 17 to 27 g) were housed on a 12-hour light/dark cycle with ad libitum access to food and water. Body weights of both sem mice and wt mice were measured weekly. Both genotypes continued to steadily increase their weight but wt mice were measurably larger than that of sem mice throughout the experimental periods. This study was carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health, and the protocol was approved by the Committee on the Ethics of Animal Experiments of Saitama Medical University (approved number 673).
Nerve crush injury model
All surgical procedures were carried out under sodium pentobarbital anesthesia (30 to 50 mg/kg, injected intraperitoneally). The left sciatic nerve was exposed through a gluteal muscle-splitting approach. A crush injury was then applied to the nerve at 5 mm distal to the sciatic notch using a brain aneurysm clip (Sugita clip; Mizuho Ikakogyo, Tokyo, Japan). The clip was left in place for three minutes with a holding force of approximately 250 g.
Twenty mice were divided into two equal groups: p38α mutant mice (sem mice; n = 10) and wild-type littermate mice (wt mice; n = 10). These mice were assessed by immunohistochemistry (see below) for the expression of TNF-α, IL-1β, Caspase-3 and Tenascin-C at three days after crush injury. Functional evaluation of nerve recovery and histological assessment including the expression of TNF-α, IL-1β and of S-100 at four weeks after crush injury were investigated through the use of another cohort of mice (n = 10 per group).
At four weeks after crush injury, specimens of the crushed sciatic nerve were taken at 5 mm distal to the injury site and fixed with PBS containing 1.85% paraformaldehyde (PFA, pH 7.4) and 0.25% glutaraldehyde, as described previously [19, 20]. As controls, tissue specimens were also taken from the contralateral uninjured sciatic nerve. All specimens were post-fixed with 2% osmium tetroxide, dehydrated in serially increasing concentrations of alcohol and ether, and then embedded in Epon resin (Quetol 512; Nisshin EM, Tokyo, Japan). Each section (1 μm in thickness) was stained with toluidine blue and examined under a light microscope. For the morphometric study of the sciatic nerve, three consecutive sections of one nerve were chosen, and a set of three non-overlapping fields was evaluated using random sampling from each section. The evaluated area covered approximately two-thirds of the total area of one nerve section. These were analyzed using ImageJ software (ver. 1.38, NIH, http://rsbweb.nih.gov/ij/).
Morphometric measurements of the sciatic nerve included: 1) axon (fiber without myelin sheath) diameter distribution; 2) average axon diameter (μm); 3) average axon area (μm2); 4) average axon number (N); 5) average axon density (N/mm2); 6) average G-ratio (quotient axon diameter / fiber diameter, a measure of the degree of myelination); and 7) average myelin sheath thickness (μm).
All animals underwent walking track analysis, as described previously . Paw prints were recorded by moistening the hind paws of each animal with blue ink and having them walk unassisted along a 6 × 44 cm corridor underlain with white construction paper. All tracks were analyzed in a blinded fashion before crush injury (0 week), and 1, 2, 3, 4 weeks following crush injury. Prints for measurement were chosen for clarity and consistency at a point when the mouse was walking at a moderate pace. If necessary, the animals were walked multiple times in order to obtain measurable prints. The tracks were evaluated for two different parameters: toe spread (TS), being the distance between the first and fifth toes, and print length (PL), the distance between the third toe and the hind pad. Measurements of all the parameters were made for the right (control) and the left (experimental) paw prints, and the sciatic functional index (SFI) was calculated according to the formula: SFI = 118.9 (ETS - NTS) / NTS - 51.2 (EPL - NPL) NPL - 7.5, where ETS is experimental TS, NTS is control TS, EPL is experimental PL and NPL is control PL.
The SFI value characterizes crucial aspects of locomotion activities, involving recovery of hind limb sensory and motor function. It varies from 0 to −100, with 0 corresponding to normal function and −100 corresponding to complete dysfunction.
Immunohistochemical examination of the nerve was performed at both three days and four weeks after crush injury. Specimens were taken from the sciatic nerve at 5 mm distal to the crush lesion, and fixed for three hours followed by cryoprotection in 30% sucrose for six hours. They were subsequently embedded in optimal cutting temperature (OCT) compound and were frozen at −80°C. Serial sagittal sections of 20 μm were cut on a cryostat and mounted on silane-coated slides. After washing with PBS, they were treated with 0.3% H2O2 in 90% methanol for 30 minutes to inactivate endogenous peroxidase. The sections were rinsed with PBS for 30 minutes and treated with 10% normal goat blocking serum in PBS for one hour at room temperature to block non-specific protein binding. Sections were then incubated overnight at room temperature in a humidified chamber with antibody. Polyclonal rabbit anti TNF-α and monoclonal mouse anti S-100 antibodies were purchased from Abcam (Cambridge, MA, USA). Polyclonal rabbit anti IL-1β antibody was purchased from Santa Cruz Biotech (Santa Cruz, CA, USA). Polyclonal rabbit anti Caspase-3 antibody and rabbit anti Tenascin-C antibody were purchased from Lifespan Bioscience (Seattle, WA, USA). The secondary antibody and detection systems were Vectastain ABC kit and DAB peroxidase substrate kit (Vector Lab., Burlingame, CA, USA). Furthermore, the sections for S-100 immunohistochemistry were counterstained with hematoxylin to evaluate cellularity.
For the immunohistochemical study of the sciatic nerve, specimens were analyzed at 400x magnification and a density threshold was set for each section to identify the immunopositive area using ImageJ software (ver. 1.38, NIH). The ratio of the immunopositive area to the total area of the field was calculated as the immunopositive rate (%). For the evaluation of cellularity, the number of cells per microscopic field was counted and expressed as the cell density (N/mm2). These analyses were performed using three non-overlapping microscopic fields, which were randomly selected from each section. The evaluated area covered approximately two-thirds of the total area of one nerve section. All histological and immunohistochemical evaluations were performed by an investigator who was blinded to the genotype and injury status of the mice.
Western blot analysis
Western Blotting of sciatic nerve protein was performed at four weeks after crush injury. Specimens were taken from the sciatic nerve at 5 mm distal to the crush lesion and from the contralateral uninjured sciatic nerve. These specimens were homogenized in lysis buffer (20 mM Hepes, pH 7.4, 2 mM EGTA, 50 mM β-glycerophosphate, 0.1% Triton X-100, 10% glycerol, 1 mM dithiothreitol, 1 μg/ml leupeptin, 5 μg/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate). After centrifugation at 10,000 × g for 15 minutes at 4°C, the supernatants were electrophoresed on a 10% SDS-polyacrylamide gel and blotted onto polyvinylidene difluoride membranes. Immunoblot detection was performed with the corresponding polyclonal rabbit anti TNF-α antibody (Abcam) and polyclonal rabbit anti IL-1β antibody (Santa Cruz Biotech) using a ECL detection kit (Amersham Pharmacia Biotech, Buckinghamshire, UK). The membranes were then stripped and reprobed with polyclonal rabbit anti-β-actin antibody (Santa Cruz Biotech), which was used as control for protein loading. Band intensities at each time point (n = 3 samples per group) were analyzed and quantified as relative density against control.
All values of morphometric parameters from histological studies, functional studies, immunohistochemical studies and western blot analysis were expressed as means ± S.D. All statistical analyses were assessed using Student’s t test. A value for P < 0.05 was considered to be statistically significant.
Morphometric parameters of the nerve at four weeks after crush injury
Axon diameter (μm2)
Axon area (μm2)
Axon number (N)
Axon density (N/mm2)
Myelin sheath thickness (μm)
Activation of p38 MAPK, and proinflammatory cytokines such as TNF-α and IL-1β, is considered to be regulated by interactions between these cytokines. It has been reported that systemic administration of p38 inhibitors results in reduced synthesis of TNF-α and IL-1β , and that p38 MAPK is activated by TNF-α , leading to induction of cell proliferation and/or apoptosis . TNF-α is also known to activate p38 MAPK in Schwann cells, by upregulating the expression of IL-1β and increasing nerve growth factor (NGF) secretion [13, 23]. The relationship between TNF-α and p38 MAPK is one of positive feedback in that TNF-α phosphorylates p38 MAPK, resulting in upregulation of TNF-α biosynthesis in the same cell type . To investigate the effect of p38 MAPK on cytokine expression after crush injury, we determined the expression of TNF-α and IL-1β in the sciatic nerve using immunohistochemistry.
Next, we investigated the expression of Tenascin-C, an oligomeric glycoprotein of the extracellular matrix, which is diffusely expressed during neurogenesis in the peripheral nervous system . It is also reported that the expression of Tenascin-C occurs within two days after removal of epiperineurium as part of the regenerative response  and its upregulation is an important prerequisite for axonal regrowth after peripheral nerve injury . At three days after nerve injury, intense Tenascin-C-ir lesions were found in the entire area of the endoneurium in the sciatic nerves in wt mice but fewer lesions were observed in sem mice. The Tenascin-C positive rates in sem and wt mice were 1.2 ± 0.9% and 6.3 ± 2.2%, respectively, which was significantly different (P < 0.01) (Figure 4b). In the contralateral nerve specimens, the expression of Tenascin-C was observed only in the perineurium (data not shown). Together, these results indicate that p38 MAPK might cause TNF-α and IL-1β upregulation in the crush injured nerve lesion and play a positive role for axonal regrowth following Wallerian degeneration at early phase after injury.
Western blot analysis
Peripheral nerves are known to have a considerable capacity for regeneration after injury, a process regulated by several inflammatory cytokines expressed within the injured nerve. An understanding of the function of inflammatory cytokines and cytokine-regulatory proteins during nerve regeneration offers the potential for broad-reaching therapeutic intervention. Therefore, this regulated complex signaling cascade has been an area of intense investigation.
The p38 MAPK is one of the most important kinases in regulating the inflammatory signaling cascade, so that many different p38 MAPK inhibitors, all of which are competitive with ATP, have been used to investigate the physiological role of p38 MAPK in vitro. Of these, SB203580, the pyridinyl imidazole compound, has been widely used as a specific inhibitor of p38 MAPK. However, it was recently revealed that this inhibitor affects several unrelated kinases, therefore, incorrect conclusions might have been drawn from numerous experiments in which SB 203580 was used as a ‘specific’ p38 inhibitor . Thus, it is of importance to explore ‘specific’ methods to block the phosphorylation of specific substrates mediated by p38 MAPK. This is the first report showing the physiological role of p38 MAPK in vivo by specifically blocking its docking-domain. Recently, we confirmed by immuno-precipitation that p38 MAPK derived from sem mice maintains interactions with transcription factors, including activating transcription factor 2 (ATF2) but not with protein kinases such as mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2) . This finding indicates that sem mice can be used to investigate limited loss-of-function of p38 MAPK. Using these mutant mice, we have confirmed that p38 MAPK insufficiency delays nerve regeneration following crush injury, both histologically and functionally.
George et al.  reported that TNF-α was increased in the injured mouse sciatic nerve on day 1 and returned to the control level on day 7 after crush injury. There are also several reports showing that endoneurial TNF protein expression peaked early and transiently in mouse sciatic nerves at the site of lesion [30, 31]. It has been reported that TNF-α functioned as a primary mediator to initiate the cascade of nerve degenerative events, inducing many changes in Schwann cells and neuron gene expression [2, 3]. Consequently, TNF-α is recognized as a biomarker of Wallerian degeneration in the injured nerve. Direct injection of TNF-α into uninjured nerves causes demyelination, macrophage infiltration, and pain, mimicking changes observed in injury [3, 32].
On the other hand, IL-1β is known to have several beneficial effects on the nervous system, promoting Schwann cell proliferation , neuron survival [34, 35], synthesis of nerve growth factor (NGF) , and oligodendrocyte remyelination . Furthermore, it has also been reported that IL-1β overcomes neurite outgrowth inhibition by deactivating the small GTPase RhoA, which results in promoting nerve regeneration. Temporin et al.  reported that expression of IL-1β was increased one day after nerve injury, and that this increase in expression persisted for 7 days. Taken together, it is considered that the expression of both TNF-α and IL-1β is indispensable for the early phase of nerve regeneration after injury.
In this study, the expression of TNF-α and IL-1β in p38 MAPK-insufficient sem mice was significantly lower than that in wt mice at three days after crush injury. This result implies that p38 MAPK functions as an upstream signal of TNF-α and IL-1β in vivo, and also suggests that reduced expression of these cytokines may be an obstacle to fulfill Wallerian degeneration and subsequent regeneration in the early phase after injury. It has been reported that adult dorsal root ganglion neurons in culture do not extend neurites in cryosections of normal sciatic nerve, but do on cryosections of pre-degenerated nerves . Wallerian degeneration, which is induced by TNF-α, is required for nerve regeneration. Therefore, this might be one of the mechanisms by which regeneration is retarded in the mutant mice. However, intriguingly, we observed elevated TNF-α expression at four weeks after crush injury in sem mice. It is well known that the activation of p38 MAPK occurs transiently followed by its dephosphorylation. However, in sem mice, the expression of phosphorylated p38 MAPK is prolonged due to an inability to bind its substrates, such as MAPKAPK2. This impairment of p38 MAPK autorepression might be one of the reasons for the elevation of TNF-α at four weeks after crush injury. We consider that this prolonged expression of TNF-α might be deleterious for successful nerve regeneration. Agents that target TNF-α and IL-1β have received attention as potential therapeutics for nerve injury, due to their inflammatory effect. However, whether clinical application of neutralizing antibody and/or receptor antagonist of these would be effective has not reached consensus. It is likely that TNF-α and IL-1β play different roles at different phases of nerve regeneration. Therefore, further studies are required to elucidate the molecular mechanisms regulating inflammation in the nervous system.
Previously, it has been reported that the expression of Caspase-3 is upregulated in the endoneurium at ten days after nerve transection , and that Tenascin-C demonstrates peak expression during the first two weeks after nerve injury and becomes downregulated subsequently when axons regenerate [40, 41]. Our results in wt mice are consistent with these previous data, and indicate that elevation of Caspase-3 followed by expression of Tenascin-C are important early responses in injured peripheral nerves. In this study, expression both Caspase-3 and Tenascin-C was significantly lower in sem mice than that in wt mice. This result supports the idea that the inhibition of p38 MAPK retarded Wallerian degeneration and subsequent axonal regeneration after nerve injury.
We also confirmed that the expression of S-100 was inhibited in sem mice and the cellularity in sem mice was higher than that in wt mice at four weeks after crush injury. This decreased expression of S-100 in the late phase after injury was consistent with previous findings  and the increase in cellularity is not surprising, given the attendant changes in the progressing degenerating-regenerating nerve . We consider these changes to also be secondary to the insufficiency of p38 MAPK and of TNF-α and IL-1β in sem mice.
In this report, we describe the specific inhibition of p38 MAPK in vivo without the use of chemical inhibitors, and we have confirmed for the first time that the inhibition of p38 MAPK delays nerve regeneration following crush injury, both histologically and functionally. Our findings suggest that molecular targets to regulate the repair of damaged peripheral nerves might exist in the p38 MAPK signaling pathway. We did not evaluate either the intrinsic responses of the neurons in dorsal root ganglia or changes of non-myelinated axons in sciatic nerves in this study. However, our current findings support the approach of specific modulation of inflammatory responses in the treatment of peripheral nerve injury. Further studies are now required to clarify the physiological role of the p38 MAPK signaling pathway for nerve regeneration.
This is the first study of the physiological role of p38 MAPK in nerve regeneration that does not rely on the use of pharmacological inhibitors. Our results indicate that p38α insufficiency may cause an inflammatory process disorder, resulting in a delay of histological and functional nerve recovery following crush injury. We conclude that p38 MAPK has an important physiological role in nerve regeneration and may be important for controlling both initiation of inflammation and recovery from nerve injury.
Experimental print length
Experimental toe spread
Mitogen-activated protein kinase
Mitogen-activated protein kinase-activated protein kinase 2
MAPK kinase kinase
Nerve growth factor
Control print length
Control toe spread
Optimal cutting temperature
Rip-like interacting caspase-like apoptosis-regulatory protein kinase
Receptor interacting protein kinase
- sem mice:
sevenmaker type Mapk14 mice
Sciatic functional index
We thank M, Sekikawa for technical support of immunohistochemistry, and also thank Y, Miyagi, Y, Nakano and A, Chiba for technical assistant of mice transportation and maintenance including genotyping. This work was partially supported by Grants-in-Aid for Scientific Research, Japan Orthopaedics and Traumatology Foundation, the Nakatomi Foundation, Kanzawa Medical Research, Kowa Life Science, Uehara Memorial, Japan Diabetes and Life Science Foundations, and by Grants from Ochiai Memorial Award and Maruki Memorial Award and Saitama Medical University internal research grant.
- Stoll G, Jander S, Myers RR: Degeneration and regeneration of the peripheral nervous system: from Augustus Waller’s observations to neuroinflammation. J Peripher Nerv Syst 2002, 7:13–27.View ArticlePubMedGoogle Scholar
- Myers RR, Wagner R, Sorkin LS: Hyperalgesia actions of cytokines on the peripheral nervous system. In Cytokines and Pain: Progress in Inflammation Research. Edited by: Watkins L. Basal: Birkhauser Verlag; 1999:133–158.View ArticleGoogle Scholar
- Wagner R, Myers RR: Schwann cells produce TNF-alpha: expression in injured and non-injured nerves. Neuroscience 1996, 73:625–629.View ArticlePubMedGoogle Scholar
- George A, Buehl A, Sommer C: Wallerian degeneration after crush injury of rat sciatic nerve increases endo- and epineurial tumor necrosis factor-alpha protein. Neurosci Lett 2004, 372:215–219.View ArticlePubMedGoogle Scholar
- Schaeffer HJ, Weber MJ: Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999, 19:2435–2444.View ArticlePubMedPubMed CentralGoogle Scholar
- Nakahara S, Yone K, Sakou T, Wada S, Nagamine T, Niyama T, Ichijo H: Induction of apoptosis signal regulating kinase 1 (ASK1) after spinal cord injury in rats: possible involvement of ASK1-JNK and -p38 pathways in neuronal apoptosis. J Neuropathol Exp Neurol 1999, 58:442–450.View ArticlePubMedGoogle Scholar
- Martin-Blanco E: p38 MAPK signalling cascades: ancient roles and new functions. Bioessays 2000, 22:637–645.View ArticlePubMedGoogle Scholar
- Cohen P: The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol 1997, 7:353–361.View ArticlePubMedGoogle Scholar
- Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R, Nebreda AR: Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 2000, 6:109–116.View ArticlePubMedGoogle Scholar
- Okada Y, Ueshin Y, Isotani A, Saito-Fujita T, Nakashima H, Kimura K, Mizoguchi A, Oh-hora M, Mori Y, Ogata M, Oshima RG, Okabe M, Ikawa M: Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer. Nature Biotechonol 2007, 25:233–237.View ArticleGoogle Scholar
- Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC: SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995, 364:229–233.View ArticlePubMedGoogle Scholar
- Temporin K, Tanaka H, Kuroda Y, Okada K, Yachi K, Moritomo H, Murase T, Yoshikawa H: Interleukin-1 beta promotes sensory nerve regeneration after sciatic nerve injury. Neurosci Lett 2008, 440:130–133.View ArticlePubMedGoogle Scholar
- Myers RR, Sekiguchi Y, Kikuchi S, Scott B, Medicherla S, Protter A, Campana WM: Inhibition of p38 MAP kinase activity enhances axonal regeneration. Exp Neurol 2003, 184:606–614.View ArticlePubMedGoogle Scholar
- Godl K, Wissing J, Kurtenbach A, Habenberger P, Blencke A, Gutbrod H, Salassidis K, Stein-Gerlach M, Missio A, Cotton M, Daub H: An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc Natl Acad Sci USA 2003, 100:15434–15439.View ArticlePubMedPubMed CentralGoogle Scholar
- Jr Mayor F, Jurado-Pueyo M, Campos PM, Murga C: Interfering with MAP kinase docking interactions: implications and perspective for the p38 route. Cell Cycle 2007, 6:528–533.View ArticleGoogle Scholar
- Tanoue T, Adachi M, Moriguchi T, Nishida E: A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol 2000, 2:110–116.View ArticlePubMedGoogle Scholar
- Hutter D, Chen P, Barnes J, Liu Y: Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. J Biochem 2000, 352:155–163.View ArticleGoogle Scholar
- Fujikawa T, Yoshimatsu T, Murakami T, Ishimaru M, Mori Y, Ogata M: Mutation of p38 MAPK in mice reduces adipose tissue weight and protects from high fat diet-induced obesity. Seikagaku 2005, 77:943.Google Scholar
- Kato N, Nakanishi K, Nemoto K, Morishita R, Kaneda Y, Uenoyama M, Ikeda T, Fujikawa K: Efficient gene transfer from innervated muscle into rat peripheral and central nervous systems using a non-viral haemagglutinating virus of Japan (HVJ)-liposome method. J Neurochem 2003, 85:810–815.View ArticlePubMedGoogle Scholar
- Kato N, Nemoto K, Nakanishi K, Morishita R, Kaneda Y, Uenoyama M, Ikeda T, Fujikawa K: Nonviral HVJ (hemagglutinating virus of Japan) liposome-mediated retrograde gene transfer of human hepatocyte growth factor into rat nervous system promotes functional and histological recovery of the crushed nerve. Neurosci Res 2005, 52:299–310.View ArticlePubMedGoogle Scholar
- Inserra MM, Bloch DA, Terris DJ: Functional indices for sciatic, peroneal, and posterior tibial nerve lesions in the mouse. Microsurgery 1998, 18:119–124.View ArticlePubMedGoogle Scholar
- Lee YB, Schrader JW, Kim SU: p38 MAP kinase regulates TNF-a production in human astrocytes and microglia by multiple mechanisms. Cytokine 2000, 12:874–880.View ArticlePubMedGoogle Scholar
- Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal JJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739–746.View ArticlePubMedGoogle Scholar
- Stenberg L, Kanje M, Dolezal K, Dahlin LB: Expression of activating transcription factor 3 (ATF3) and caspase 2 in Schwann cells and axonal outgrowth after sciatic nerve repair in diabetic BB rats. Neurosci Lett 2012, 515:34–38.View ArticlePubMedGoogle Scholar
- Maeno I, Ishizaki Y, Kanaseki T, Hazama A, Okada Y: Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci USA 2000, 97:9487–9492.View ArticlePubMedPubMed CentralGoogle Scholar
- Nishimura T, Hirata H, Tsujii M, Iida R, Hoki Y, Iino T, Ogawa S, Uchida A: Pathomechanism of entrapment neuropathy in diabetic and nondiabetic rats reared in wire cages. Histol Histopathol 2008, 23:157–166.PubMedGoogle Scholar
- Yamamoto M, Okui N, Tatebe M, Shinohara T, Hirata H: Regeneration of the perineurium after microsurgical resection examined with immunolabeling for tenascin-C and alpha smooth muscle actin. J Anat 2011, 218:413–425.View ArticlePubMedPubMed CentralGoogle Scholar
- Fruttiger M, Schachner M, Martini R: Tenascin-C expression during Wallerian degeneration in C57BL/Wlds mice: possible implications for axonal regeneration. J Neurocytol 1995, 24:1–14.View ArticlePubMedGoogle Scholar
- George A, Buehl A, Sommer C: Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve. Exp Neurol 2005, 192:163–166.View ArticlePubMedGoogle Scholar
- Shamash S, Reichert F, Rotshenker S: The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J Neurosci 2002, 22:3052–3060.PubMedGoogle Scholar
- Sawada T, Sano M, Omura T, Omura K, Hasegawa T, Funahashi S, Nagano A: Spatiotemporal quantification of tumor necrosis factor-alpha and interleukin-10 after crush injury in rat sciatic nerve utilizing immunohistochemistry. Neurosci Lett 2007, 417:55–60.View ArticlePubMedGoogle Scholar
- Sorkin LS, Xiao WH, Wagner R, Myers RR: Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 1997, 81:255–262.View ArticlePubMedGoogle Scholar
- Conti G, De Pol A, Scarpini E, Vaccina F, De Riz M, Baron P, Tiriticco M, Scarlato G: Interleukin-1 beta and interferon-gamma induce proliferation and apoptosis in cultured Schwann cells. J Neuroimmunol 2002, 124:29–35.View ArticlePubMedGoogle Scholar
- Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC: Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol 1999, 163:3963–3968.PubMedGoogle Scholar
- Diem R, Hobom M, Grotsch P, Kramer B, Bahr M: Interleukin-1 beta protects neurons via the interleukin-1 (IL-1) receptor-mediated Akt pathway and by IL-1 receptor-independent decrease of transmembrane currents in vivo. Mol Cell Neurosci 2003, 22:487–500.View ArticlePubMedGoogle Scholar
- Lindholm D, Heumann R, Meyer M, Thoenen H: Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987, 330:658–659.View ArticlePubMedGoogle Scholar
- Mason JL, Suzuki K, Chaplin DD, Matsushima GK: Interleukin- 1beta promotes repair of the CNS. J Neurosci 2001, 21:7046–7052.PubMedGoogle Scholar
- Bedi KS, Winter J, Berry M, Cohen J: Adult rat dorsal root ganglion neurons extend neurites on predegenerated but not on normal peripheral nerves in vitro. Eur J Neurosci 1992, 4:193–200.View ArticlePubMedGoogle Scholar
- Kuhlmann T, Bitsch A, Stadelmann C, Siebert H, Brück W: Macrophages are eliminated from the injured peripheral nerve via local apoptosis and circulation to regional lymph nodes and the spleen. J Neurosci 2001, 21:3401–3408.PubMedGoogle Scholar
- Martini R, Schachner M, Faissner A: Enhanced expression of the extracellular matrix molecule J1/tenascin in the regenerating adult mouse sciatic nerve. J Neurocytol 1990, 19:601–616.View ArticlePubMedGoogle Scholar
- Daniloff JK, Crossin KL, Pincon-Raymond M, Murawsky M, Rieger F, Edelman GM: Expression of cytotactin in the normal and regenerating neuromuscular system. J Cell Biol 1989, 108:625–635.View ArticlePubMedGoogle Scholar
- Kato K, Satoh T: Changes in the concentration of enolapse isozymes and S-100 protein in degenerating and regenerating rat sciatic nerve. J Neurochem 1983, 40:1076–1081.View ArticlePubMedGoogle Scholar
- Myers RR: Morphology of the peripheral nervous system and its relationship to neuropathic pain. In Anesthesia: Biologic Foundations. Edited by: Yaksh TL. Philadelphia: Lippincott-Raven Publishers; 1997:483–513.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.